Inform Network
The International Network for Fatty Acid Oxidation Research and Management was formed by Jerry Vockley in order to promote research and discussion into the cause, diagnosis, and management of fatty acid oxidation disorders (FAODs). We offer several learning opportunities throughout the year for patients, families, and researchers. Our network will provide a collaborative framework for ongoing communication and research regarding these disorders, as well as work with our partners to sponsor a symposium each year. Please plan to join us in the future to hear from the experts on a wide range of topics from molecular pathophysiology to treatment strategies.
Abstracts
We believe in the power of fatty acid oxidation research to gain a better understanding of these disorders. You can review abstracts from INFORM Network’s previous international symposiums or submit an abstract for our 2020 conference in Freiburg, Germany, scheduled for August 30th and 31st, preceding the SSIEM.
Virtual Tissue Bank
The Virtual Tissue Bank (VTB) grew out of the desire to share research sample information and testing results to help advance the diagnosis and treatment of fatty oxidation disorders and the carnitine cycle in order to increase knowledge and help patients worldwide.
INFORM Families
At INFORM Network, we offer a comprehensive resource for families and friends impacted by fatty acid oxidation disorders. Here you can learn the latest developments in genetic research and access important information on screening, diagnosis, and treatment.
Sponsor INFORM 2019 Conference
Our 2019 FAOD conference and symposium in Amsterdam, The Netherlands will discuss the proper diagnostic interpretation of laboratory testing, the development of new therapeutic strategies, and the role of newborn screening in preventing complications. It will also serve as our annual meeting.
Research Webinars
Upcoming INFORM Webinars:
Watch Previous Webinars Below
5/21/2018
Enhancing Expression and Chaperoning Unstable Proteins:
Getting closer to effective therapy for fatty acid b-oxidation disorders
Al-Walid Mohsen, PhD Research Associate Professor of Pediatrics Medical Genetics,
Children’s Hospital of Pittsburgh / University of Pittsburgh.
4/23/2018
Loss of Retinal Pigment Epithelium: The Initial Event in LCHAD Retinopathy Progression?
Melanie Gillingham, PhD, RD / Associate Professor /Department of Molecular and Medical Genetics
Graduate Programs in Human Nutrition / Oregon Health & Science University
Modeling LCHAD Retinopathy in a Patient Derived Retinal Pigment Epithelium
Tiffany DeVine, PhD / Postdoctoral researcher /Department of
Molecular and Medical Genetics
Oregon Health & Science University
2/5/2019
Novel Therapies for Fatty Acid Oxidation Disorders
by Jerry Vockley, MD, PhD
6/17/2019
The Fate of Medium-Chain Fatty Acids in Very Long-Chain Acyl-CoA Dehydrogenase Deficient (VCLADD): A Matter of Sex?
Zeinab Wehbe, PhD Student, Department of General Pediatrics and Adolescent Medicine
Laboratory of Clinical Biochemistry and Metabolism
Medical Center – University of Freiburg
Faculty of Medicine, University of Freiburg
Approximately
“I appreciate that INFORM always provides us the most advanced, the most professional, and the most comprehensive information about defects of beta-oxidation.”
“Together we can generate the energy to beat these diseases”
“INFORM brings together the best and brightest researchers and physicians from around the world to discuss cutting edge research and best and new practices in fatty acid oxidation disorders.”
“The challenge with being on the cutting edge is that you are always dealing with things that didn’t happen yesterday”.
2019 Sponsors
Thank you for your part in supporting this important conference. We promise to provide all our attendees another wonderful INFORM Symposium planned for September 1st & September 2nd 2019 in Amsterdam, The Netherland preceding the SSIEM in Rotterdam. Please accept our deepest appreciation for your investment in INFORM.
Unlocking the Future
We are committed to discovering new FAOD treatments and cures to improve the lives of our patients and their families.